These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6610200)

  • 81. The mechanism of lysine-vasopressin hemostasis in bleeding esophageal varices.
    Aronsen KF; Björkman I; Lindström K; Nylander G; Mulder J
    Acta Chir Scand; 1979; 145(4):231-4. PubMed ID: 315146
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Time profile of the haemodynamic effects of terlipressin in portal hypertension.
    Escorsell A; Bandi JC; Moitinho E; Feu F; García-Pagan JC; Bosch J; Rodés J
    J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Splanchnic hemodynamic pattern and liver function in patients with cirrhosis and esophageal or gastric varices.
    Nakano R; Iwao T; Oho K; Toyonaga A; Tanikawa K
    Am J Gastroenterol; 1997 Nov; 92(11):2085-9. PubMed ID: 9362198
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of vasopressin on systemic capacity.
    Welt FG; Rutlen DL
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1494-8. PubMed ID: 1951737
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical physiologic approach to the patient with portal hypertension.
    Chiandussi L
    Bull N Y Acad Med; 1975 Apr; 51(4):557-64. PubMed ID: 1091318
    [No Abstract]   [Full Text] [Related]  

  • 86. How the lower oesophageal sphincter affects submucosal oesophageal varices.
    Miskowiak J
    Lancet; 1978 Dec; 2(8103):1284-5. PubMed ID: 82785
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Canine esophageal motor function: effects of arterial and intravenous vasopressin.
    Cho KJ; McGinnis BD
    AJR Am J Roentgenol; 1981 May; 136(5):961-4. PubMed ID: 6784535
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of propranolol on portal hemodynamics in patients with chronic liver disease.
    Ohnishi K; Nakayama T; Saito M; Hatano H; Tsukamoto T; Terabayashi H; Sugita S; Wada K; Nomura F; Koen H
    Am J Gastroenterol; 1985 Feb; 80(2):132-5. PubMed ID: 3881933
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Splanchnic clearance of plasma vasopressin in the dog: evidence for prehepatic extraction.
    Matsui K; Share L; Brooks DP; Crofton JT; Rockhold RW
    Am J Physiol; 1983 Dec; 245(6):E611-5. PubMed ID: 6660291
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Development of cutaneous gangrene during continuous peripheral infusion of vasopressin.
    Anderson JR; Johnston GW
    Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1657-8. PubMed ID: 6416538
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
    Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
    J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure.
    Kayacetin E; Efe D; Doğan C
    J Gastroenterol; 2004 Jul; 39(7):661-7. PubMed ID: 15293137
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Control of bleeding varices by vasopressin: a prospective randomized study.
    Johnson WC; Widrich WC; Ansell JE; Robbins AH; Nabseth DC
    Ann Surg; 1977 Sep; 186(3):369-76. PubMed ID: 302111
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics.
    Kleber G; Sauerbruch T; Fischer G; Paumgartner G
    Gut; 1988 Feb; 29(2):153-6. PubMed ID: 2894336
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prognostic indicators in alcoholic cirrhotic men.
    Gluud C; Henriksen JH; Nielsen G
    Hepatology; 1988; 8(2):222-7. PubMed ID: 3258578
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Correction of the unfavourable effects of vasopressin by nitroglycerin infusion.
    Lanza V; Demma I; Cali A; Castronovo G
    Can Anaesth Soc J; 1982 May; 29(3):243-9. PubMed ID: 6804067
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of two different preparations of somatostatin on intra-portal pressure in patients with liver cirrhosis.
    Thulin L
    Clin Physiol; 1984 Oct; 4(5):439-42. PubMed ID: 6541553
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Glucagon selectively increases splanchnic blood flow in patients with well-compensated cirrhosis.
    Lee SS; Moreau R; Hadengue A; Cerini R; Koshy A; Lebrec D
    Hepatology; 1988; 8(6):1501-5. PubMed ID: 3192162
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Splanchnic galactose uptake in patients with cirrhosis during continuous infusion.
    Lindskov J; Ranek L; Tygstrup N; Winkler K
    Clin Physiol; 1983 Apr; 3(2):179-85. PubMed ID: 6682739
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Active and passive liver microvascular responses from angiotensin, endothelin, norepinephrine, and vasopressin.
    Rothe CF; Maass-Moreno R
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1147-56. PubMed ID: 10993778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.